CHICAGO, July 10 Intel Corp (INTC.O), the world's
biggest computer chip maker, said on Thursday it won clearance
from the U.S. Food and Drug Administration to sell a personal
in-home health monitoring system for patients with chronic
The system, called Health Guide, combines an in-home patient
device as well as online access that enables healthcare
professionals to monitor patients and remotely manage care.
It incorporates interactive tools for personalized care
management and integrates vital sign collection, patient
reminders, multimedia educational content and feedback and
communications tools such as video conferencing and e-mail.
The Health Guide system can connect to specific models of
wired and wireless medical devices, including blood pressure
monitors, glucose meters, pulse oximeters, peak flow meters and
weight scales. It also stores and displays the collected
information on a touch screen and sends to a secure host server,
where healthcare professionals can review the information.
"With more people living with chronic diseases, we believe
care can be increasingly moved outside of the hospital to the
home," Louis Burns, vice president and general manager of Intel's
Digital Health Group, said in a prepared statement.
"We believe the Intel Health Guide represents a new category
of personal health systems that go beyond the simple remote
patient monitoring devices available today," he added.
Intel said it expects the system to be commercially available
from healthcare providers in the United States and the United
Kingdom late this year or early next year.
(Reporting by Debra Sherman, editing by Phil Berlowitz)